INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 85 filers reported holding INARI MED INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,939,613 | +5.9% | 656,569 | -5.9% | 0.01% | 0.0% |
| Q2 2023 | $40,561,313 | +4.2% | 697,649 | +10.6% | 0.01% | 0.0% |
| Q1 2023 | $38,932,998 | -9.8% | 630,596 | -7.1% | 0.01% | -11.1% |
| Q4 2022 | $43,160,227 | -12.4% | 679,047 | +0.2% | 0.01% | -18.2% |
| Q3 2022 | $49,252,000 | +16.7% | 678,028 | +9.2% | 0.01% | +22.2% |
| Q2 2022 | $42,212,000 | +20.5% | 620,845 | +60.7% | 0.01% | +50.0% |
| Q1 2022 | $35,026,000 | +12.1% | 386,430 | +12.9% | 0.01% | +20.0% |
| Q4 2021 | $31,247,000 | +13.1% | 342,364 | +0.5% | 0.01% | 0.0% |
| Q3 2021 | $27,629,000 | -1.3% | 340,668 | +13.6% | 0.01% | 0.0% |
| Q2 2021 | $27,981,000 | +52.1% | 299,975 | +74.5% | 0.01% | +66.7% |
| Q1 2021 | $18,398,000 | +107.8% | 171,937 | +69.5% | 0.00% | +50.0% |
| Q4 2020 | $8,853,000 | +25.7% | 101,413 | -0.6% | 0.00% | 0.0% |
| Q3 2020 | $7,044,000 | +730.7% | 102,052 | +483.3% | 0.00% | – |
| Q2 2020 | $848,000 | – | 17,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 220,000 | $19,941,000 | 3.19% |
| SECTORAL ASSET MANAGEMENT INC | 161,060 | $14,598,000 | 2.59% |
| Nicholas Investment Partners, LP | 221,175 | $20,047,000 | 1.43% |
| Sio Capital Management, LLC | 40,210 | $3,645,000 | 1.21% |
| Pier Capital, LLC | 98,664 | $8,943,000 | 1.14% |
| Lisanti Capital Growth, LLC | 98,325 | $8,912,000 | 1.00% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 277,863 | $25,186,000 | 0.90% |
| HARBOURVEST PARTNERS LLC | 38,540 | $3,493,000 | 0.71% |
| CNA FINANCIAL CORP | 24,513 | $2,222,000 | 0.69% |
| Monashee Investment Management LLC | 25,000 | $2,266,000 | 0.66% |